Document And Entity Information
Document And Entity Information | Jun. 18, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 18, 2024 |
Entity Registrant Name | Kezar Life Sciences, Inc. |
Entity Central Index Key | 0001645666 |
Entity Emerging Growth Company | false |
Entity File Number | 001-38542 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-3366145 |
Entity Address, Address Line One | 4000 Shoreline Court, Suite 300 |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 822-5600 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.001 par value |
Trading Symbol | KZR |
Security Exchange Name | NASDAQ |